All news

Compass Therapeutics (CMPX) executive Lerner bought 10,000 shares for $5,900 at $0.59

Alpha Vantage · Quantisnow · · AI-summarised by FinFlash

Neil Lerner, Chief Accounting Officer at Compass Therapeutics Inc. (CMPX), reported an open-market purchase of 10,000 shares for $5,900 at $0.59 on November 17, 2026. This transaction increased his direct holdings to 430,000 shares. The filing provides details on the transaction, previous holdings, and footnotes regarding unvested restricted stock units.

Read original source

CMPX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.